Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpirax-Sarco Regulatory News (SPX)

Share Price Information for Spirax-Sarco (SPX)

Share Price is delayed by 15 minutes
Get Live Data
6,395.00    95.00 (1.51%)
Bid:
6,380.00
Ask:
6,390.00
Spread: 10.00 (0.157%)
Market Cap: £4.72b
SPX Live PriceLast checked at - London Stock Exchange

Intraday Spirax-Sarco Share Chart

Board Appointment

22 Oct 2025 07:00

RNS Number : 2860E
Spirax Group PLC
22 October 2025
 

 

22 October 2025

Board Appointment

 

Spirax Group plc, the leading global thermal energy management and fluid technology solutions Group, is pleased to announce the appointment of Andrew Kemp as an Independent Non-Executive Board Director and member of the Audit Committee with effect from 1 November 2025.

 

Andrew is Chair of the Audit Committee Chairs' Independent Forum and is a Non-Executive Director and Audit Committee Chair at both The Berkeley Group Holdings plc and Irwin Mitchell Holdings Limited. In addition, Andrew is a Governor of Birkbeck University of London where he chairs the Finance Committee and he was previously a Non-Executive Director of SCS Group plc. Prior to that, Andrew spent almost 39 years serving PwC's FTSE100 clients in the UK and internationally.

 

On 1 April 2026, Andrew will succeed Kevin Thompson as Chair of the Audit Committee and Kevin will step down from the Board at the Company's Annual General Meeting (AGM) in May 2026. Until then, Kevin and Andrew will work together to manage a smooth handover.

 

Tim Cobbold, Chair, commented: "I am delighted to welcome Andrew to Spirax Group. He brings deep expertise to the Board and the Audit Committee, along with significant experience as a Non-Executive Director and Audit Committee Chair of both large listed and privately held companies.

 

"On behalf of the Board, I would like to express our thanks to Kevin for his significant contribution to Spirax Group. Kevin's extensive experience and commitment have been instrumental in guiding Spirax Group through some important milestones as the business has grown and developed. When Kevin steps down at the AGM next year to spend more time with family and friends, he will leave with our utmost appreciation and good wishes for the future."

 

Andrew Kemp's appointment is part of the succession planning undertaken by the Nomination Committee to recruit Non-Executive Directors with the skills and experience required to support the implementation of the Group's Together for Growth Strategy.

 

There are no further disclosures to be made pursuant to UKLR 6.4.6R and 6.4.8R.

 

For further information:

Celine Barroche, General Counsel and Company Secretary

+44 (0) 1242 535 276

 

Media

Martin Robinson, Teneo:

+44 (0) 20 7260 2700

 

spiraxgroup@teneo.com

 

 

About Spirax Group

Spirax Group is positioned to play a critical role in enabling the industrial transition to net zero, aligned to our Purpose to create sustainable value for all our stakeholders as we engineer a more efficient, safer and sustainable world. We put solving customers' problems at the heart of our 'total solutions' approach. Our global thermal energy and fluid technology solutions improve operating efficiency and safety in our customers' critical industrial processes. Our decarbonisation solutions use proprietary technologies to eliminate scope 1 and 2 greenhouse gas emissions* by electrifying boilers for the raising of steam, as well as the electrification of other critical industrial process heating applications.

Spirax Group comprises three strong and aligned Businesses: Steam Thermal Solutions helps customers control and manage steam within their mission critical industrial applications, such as cleaning, sterilising, cooking and heating. We are helping to put food safely on the world's tables and keeping our hospitals running. Electric Thermal Solutions has proprietary technologies that deliver electrification solutions at scale in industrial settings, including for the raising of steam, supporting our customers to achieve their net zero goals. We also deliver freeze protection and defrost solutions critical to aviation and space industries and ensure thermal uniformity in Semiconductor chip manufacturing to power the critical electronic systems we rely on. Watson‐Marlow Fluid Technology Solutions is optimising the efficient use of resources and supporting advancements in global health, such as lifesaving vaccines and gene therapies.

Spirax Group is headquartered in Cheltenham (UK). We have 37 strategically located manufacturing plants around the world and are committed to creating a safe and inclusive working culture for our 10,000 colleagues, operating in 66 countries and serving 110,000 customers globally. The Company's shares have been listed on the London Stock Exchange since 1959 (symbol: SPX) and we are a constituent of the FTSE 100 and the FTSE4Good Indexes.

*When connected to a green electricity source.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFLFIDIALLFIE
Date   Source Headline
25th Aug 20238:30 amRNSHolding(s) in Company
10th Aug 20237:00 amRNS2023 Half Year Results
8th Aug 20237:00 amRNSGroup Chief Executive Succession
2nd Aug 20238:00 amRNSBoard Appointment
1st Aug 20239:09 amRNSDirector/PDMR Shareholding
27th Jul 20239:30 amRNSChange in Director Details
26th Jun 202310:00 amRNSNotice of Investment Seminar
22nd Jun 20232:03 pmRNSHolding(s) in Company
22nd Jun 20237:00 amRNSKyoto Investment and Partnership Agreement
14th Jun 202310:42 amRNSHolding(s) in Company
9th Jun 20235:45 pmRNSHolding(s) in Company
24th May 20232:46 pmRNSHolding(s) in Company
10th May 20233:23 pmRNSResult of AGM
10th May 20237:00 amRNSAGM Trading Update
16th Mar 20234:22 pmRNSDirector/PDMR Shareholding
16th Mar 20239:00 amRNSDirector/PDMR Shareholding
15th Mar 20234:12 pmRNSDirector/PDMR Shareholding
15th Mar 20239:53 amRNSDirector/PDMR Shareholding
15th Mar 20239:48 amRNSHolding(s) in Company
13th Mar 20231:31 pmRNSDirector/PDMR Shareholding
13th Mar 202312:22 pmRNSDirector/PDMR Shareholding
9th Mar 20237:00 amRNS2022 Full Year Results
8th Mar 20233:09 pmRNSChange of Director Details
21st Feb 202310:32 amRNSHolding(s) in Company
31st Jan 20239:30 amRNSBoard Changes
30th Jan 20236:04 pmRNSHolding(s) in Company
23rd Dec 202210:31 amRNSDirector/PDMR Shareholding
1st Dec 20227:00 amRNSCompletion of the Acquisition of Durex Industries
17th Nov 20227:00 amRNSTrading Statement
27th Oct 20224:24 pmRNSDirector/PDMR Shareholding
4th Oct 20227:00 amRNSDirector/PDMR Shareholding
30th Sep 20227:00 amRNSCompletion of the acquisition of Vulcanic
28th Sep 20227:00 amRNSAcquisition of US Thermal Energy Specialist
6th Sep 202212:41 pmRNSDirector/PDMR Shareholding
11th Aug 20227:00 amRNS2022 Half Year Results
25th Jul 20227:30 amRNSVulcanic Acquisition Agreement Executed
4th Jul 202211:04 amRNSAmendment to 0126R - Director/PDMR Shareholding
4th Jul 20227:30 amRNSExclusive negotiations to acquire Vulcanic
1st Jul 202210:37 amRNSDirector/PDMR Shareholding
29th Jun 20227:00 amRNSInvestor Seminar
22nd Jun 20227:00 amRNSDirector/PDMR Shareholding
22nd Jun 20227:00 amRNSDirector/PDMR Shareholding
20th Jun 20227:00 amRNSDirector/PDMR Shareholding
23rd May 202210:48 amRNSElectric Thermal Solutions Business Update
23rd May 20229:08 amRNSDirector/PDMR Shareholding
11th May 20223:02 pmRNSResult of AGM
11th May 20227:00 amRNSAGM Trading Update
19th Apr 20223:10 pmRNSDirector/PDMR Shareholding
14th Apr 202212:00 pmRNSChange of Director Details
21st Mar 202210:10 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.